Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 14, 2018
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018
SAN DIEGO, May 14, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® ...
May 14, 2018
Zealand hosts conference call on May 16 at 4 pm CET/10 am EDT to present first quarter results 2018
Copenhagen, May 14, 2017 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that it will be hosting a conference call on ...
May 14, 2018
CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use
MONMOUTH JUNCTION, N.J., May 14, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly ...
May 14, 2018
Arrowhead Doses First Hepatitis B Patients in Multiple Dose Portion of Phase 1/2 Study of ARO-HBV
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it has dosed the first 3 hepatitis B virus (HBV) patients in the multiple-ascending dose portion ...
May 14, 2018
Auris Medical to Report First Quarter 2018 Financial Results and Provide Business and Strategy Update on Tuesday, May 15, 2018
Zug, Switzerland, May 14, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
May 14, 2018
Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference
EMERYVILLE, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
May 14, 2018
Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
REDWOOD CITY, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
May 14, 2018
RedHill Biopharma to Host Investor Webcast on RHB-104 for Crohn’s Disease on May 15
TEL-AVIV, Israel and RALEIGH, N.C., May 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
May 14, 2018
BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights
NEW YORK, N.Y. and PETACH TIKVAH, Israel, May 14, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies ...
May 14, 2018
PolarityTE Acquires Operating GLP/USDA Preclinical Biomedical Research Facility and Announces Caroline Garrett DVM from Johns Hopkins as Chief Veterinary Officer at Polarity
SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (COOL) announced the acquisition of a preclinical biomedical research facility in order to accelerate ...
May 14, 2018
Oncobiologics Announces $15 Million Private Placement Offering
CRANBURY, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) (the “Company”) today announced that on May 11, 2018, it entered into a purchase ...
May 10, 2018
Sierra Oncology Reports First Quarter Results
VANCOUVER , May 10, 2018 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) ...
May 10, 2018
Keryx Biopharmaceuticals Announces First Quarter 2018 Financial Results
BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
May 10, 2018
MediWound Reports First Quarter 2018 Financial Results
YAVNE, Israel, May 10, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
May 10, 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
INDIANAPOLIS and REDWOOD CITY, Calif., May 10, 2018 /PRNewswire/ -- Eli Lilly and Company (LLY) and ARMO BioSciences, Inc. (ARMO) today announced a definitive agreement for ...
May 10, 2018
HTG Molecular Diagnostics to Feature Its HTG EdgeSeq Precision Immuno-Oncology Panel at Booth #4113 at the American Society of Clinical Oncology (ASCO) Conference in June 2018
TUCSON, Ariz., May 10, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, ...
May 10, 2018
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO, May 10, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Amit D. Munshi, President and Chief Executive Officer, will present at the following ...
May 10, 2018
Theravance Biopharma to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
DUBLIN, May 10, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer will participate in a fireside ...
May 10, 2018
Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results
WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and ...
May 10, 2018
Krystal Biotech Announces Dosing of First Patient in the Phase 1/2 trial of KB103, a First-in-Class Topical Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa
PITTSBURGH, May 10, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological ...
Page 42 of 117